Emcure Pharmaceuticals IPO

Emcure Pharmaceuticals IPO Subscription Status and Review

The Emcure Pharmaceuticals IPO has witnessed an overwhelming response from investors. On the third day of bidding, the IPO was oversubscribed with non-institutional investors leading the charge. As per the BSE data at 13:00 IST, the subscription status stood at an impressive 11.63 times. Non-institutional investors subscribed 31.67 times, retail investors booked their portion 5.36…

Read More